Skip to main content

Neurodegenerative Diseases

The research conducted in our group is geared toward elucidating the cause and molecular mechanisms of neurodegeneration in Parkinson's disease (PD), a disabling, currently incurable common neurodegenerative disorder. To this end, we perform clinical and pre-clinical translational research in both PD patients and in human-relevant experimental in vitro and in vivo PD-related models. 

Elucidating the molecular mechanisms underlying neurodegeneration in PD should allow to: 

  • Identify biomarkers for PD diagnosis, early detection, patient stratification, disease progression, prognosis or response to treatment. This is the objective of the VHIP Project that the team is carrying out.
  • Identify new molecular targets for potential therapeutic intervention and prevention.
  • Develop novel therapeutic strategies with disease-modifying potential.
  • Unravel molecular pathways common to other neurodegenerative diseases and, in a broader sense, brain aging.
     

Team

Johanna Andrea Folleco Eraso

Johanna Andrea Folleco Eraso

Predoctoral researcher
Neurodegenerative Diseases
Read more
Jorge Hernández Vara

Jorge Hernández Vara

Main researcher
Neurodegenerative Diseases
Read more
Marina Lorente Picón

Marina Lorente Picón

Predoctoral researcher
Neurodegenerative Diseases
Read more
Marta González Sepúlveda

Marta González Sepúlveda

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Pau Sarle Valles

Pau Sarle Valles

Predoctoral researcher
Neurodegenerative Diseases
Read more
Roman Serrat  Reñe

Roman Serrat Reñe

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Johanna Andrea Folleco Eraso

Johanna Andrea Folleco Eraso

Predoctoral researcher
Neurodegenerative Diseases
Read more
Jorge Hernández Vara

Jorge Hernández Vara

Main researcher
Neurodegenerative Diseases
Read more
Marina Lorente Picón

Marina Lorente Picón

Predoctoral researcher
Neurodegenerative Diseases
Read more
Marta González Sepúlveda

Marta González Sepúlveda

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Pau Sarle Valles

Pau Sarle Valles

Predoctoral researcher
Neurodegenerative Diseases
Read more
Roman Serrat  Reñe

Roman Serrat Reñe

Postdoctoral researcher
Neurodegenerative Diseases
Read more

Projects

DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES (DOCTIS)

IP: Sara Marsal Barril
Collaborators: Antonio Julia Cano, Javier Hoyo Pérez, Elena Granell Pallares, Adria Aterido Ballonga, Montse Sender Beleta, Nuria Palau Balaña, Edgar Nuñez Gallardo, Raul Tortosa Mendez, Maria Alba Erra Duran
Funding agency: EUROPEAN COMMISSION
Funding: 1079085
Reference: DOCTIS_H2020_SC1-BHC2019
Duration: 01/01/2020 - 31/12/2025

The Vall d’Hebron Iniciative for Parkinson associated to GBA (VHIP-GBA): from biospecimen collection to translational studies and therapies.

IP: Marta Martínez Vicente
Collaborators: José Antonio Arranz Amo, Jorge Hernández Vara, Eddie Pradas Gracia, Guillem Pintos Morell, Clara Carnicer Cáceres, Carles Lorenzo Bosquet, David Moreno Martinez, Jordi Riera Heredia, The Vall d’Hebron Iniciative for Parkinson associated to GBA (VHIP-GBA): from biospecimen collection to translational studies an, Daniela Samaniego Toro, Laura Castillo Ribelles, Daniela Samaniego Toro
Funding agency: Instituto de Salud Carlos III
Funding: 245932.5
Reference: PI20/00728
Duration: 01/01/2021 - 30/06/2025

Characterization of the CD8 T cell response in Parkinson’s disease for the development of preventive and therapeutic strategies that halt the progression of the disease: SARS-Cov-2-induced long term-hyposmia as a possible prodromal stage

IP: Jordi Bove Badell
Collaborators: Miquel Vila Bover, Alejandro Ferré Masó, Oriol de Fabregues-Boixar Nebot, Carles Lorenzo Bosquet, Characterization of the CD8 T cell response in Parkinson’s disease for the development of preventive and therapeutic strategies , Antonio Palasi Franco
Funding agency: Instituto de Salud Carlos III
Funding: 165770
Reference: PI21/01358
Duration: 01/01/2022 - 30/06/2026

The brain-body axis in Parkinson’s disease patients: from pathophysiology to biomarkers and therapeutic approaches

IP: Ariadna Laguna Tuset
Collaborators: Maria Victoria Gonzalez Martinez, Miquel Vila Bover, Marina Lorente Picón, Helena Xicoy Cortada, Daniela Samaniego Toro, Daniela Samaniego Toro, Sara Belmonte Calderon
Funding agency: Instituto de Salud Carlos III
Funding: 171820
Reference: PI21/01603
Duration: 01/01/2022 - 30/06/2026

Publications

Endogenous interactomes of MFN1 and MFN2 provide novel insights into interorganelle communication and autophagy.

PMID: 39675054
Journal: Autophagy
Year: 2024
Reference: Autophagy. 2024 Dec 15. doi: 10.1080/15548627.2024.2440843.
Impact factor:
Publication type: Paper in international publication
Authors: Arauz-Garofalo, Gianluca; Gay, Marina; Gordaliza-Alaguero, Isabel; Ivanova, Saska; Macias, Maria J; Martin-Malpartida, Pau; Martinez-Vicente, Marta; Palacin, Manuel; Radivojevikj, Dragana; Sanchez-Fernandez-de-Landa, Paula et al.
DOI: 10.1080/15548627.2024.2440843

Autophagy and Protein Quality Control in Parkinson's Disease.

PMID: 39694692
Journal: Cold Spring Harbor Perspectives in Medicine
Year: 2024
Reference: Cold Spring Harb Perspect Med. 2024 Dec 18:a041619. doi: 10.1101/cshperspect.a041619.
Impact factor:
Publication type: Paper in international publication
Authors: Martinez-Vicente, Marta; Vila, Miquel et al.
DOI: 10.1101/cshperspect.a041619

Developing Allosteric Chaperones for GBA1-Associated Disorders-An Integrated Computational and Experimental Approach.

PMID: 39795868
Journal:
Year: 2024
Reference: Int J Mol Sci. 2024 Dec 24;26(1):9. doi: 10.3390/ijms26010009.
Impact factor:
Publication type: Paper in international publication
Authors: Bellotto, Manolo; Carrillo, Jokin; Cubero, Elena; Delgado, Aida; Garcia-Collazo, Ana Maria; Martinez-Vicente, Marta; Montpeyo, Marta; Perez-Carmona, Natalia; Ruano, Ana et al.
DOI: 10.3390/ijms26010009

Patient selection and early withdrawal of life support in extracorporeal cardiopulmonary resuscitation (ECPR): Do we have a problem?

PMID: 39974625
Journal:
Year: 2024
Reference: Resusc Plus. 2024 Dec 19;20:100735. doi: 10.1016/j.resplu.2024.100735. eCollection 2024 Dec.
Impact factor:
Publication type: Paper in international publication
Authors: Argudo, Eduard; Martinez-Martinez, Maria; Riera, Jordi; Torrella, Pau; Vidal-Burdeus, Maria et al.
DOI: 10.1016/j.resplu.2024.100735

Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?

PMID: 37509344
Journal: Cancers
Year: 2023
Reference: Cancers (Basel). 2023 Jul 19;15(14):3683. doi: 10.3390/cancers15143683.
Impact factor:
Publication type: Paper in international publication
Authors: Carrion, Albert; Dinares, Carme; Hernandez, Javier; Hernandez, Javier; Lozano, Fernando; Morote, Juan; Raventos, Carles X; Trilla, Enrique et al.
DOI: 10.3390/cancers15143683

Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis.

PMID: 37661559
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2023
Reference: Arch Bronconeumol. 2023 Aug 7:S0300-2896(23)00267-3. doi: 10.1016/j.arbres.2023.07.029.
Impact factor:
Publication type: Letter or abstract
Authors: Abril, Elena; Barbe, Ferran; Barbera, Carme; Bustamante-Munguira, Elena; Bustamante-Munguira, Elena; Caballero, Jesus; Caballero, Jesus; Canseco, Joan; Carbonell, Nieves; Ceccato, Adrian et al.
DOI: 10.1016/j.arbres.2023.07.029

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.

PMID: 37726343
Journal: npj Parkinsons Disease
Year: 2023
Reference: NPJ Parkinsons Dis. 2023 Sep 19;9(1):135. doi: 10.1038/s41531-023-00579-w.
Impact factor:
Publication type: Paper in international publication
Authors: Arotcarena, Marie-Laure; Bezard, Erwan; Bourdenx, Mathieu; Darricau, Morgane; Dehay, Benjamin; Dovero, Sandra; Estrada, Cristina; Garcia-Carrillo, Nuria; Herrero, Maria Trinidad; Obeso, Jose A et al.
DOI: 10.1038/s41531-023-00579-w

Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?

PMID: 37741513
Journal: NEUROBIOLOGY OF DISEASE
Year: 2023
Reference: Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
Impact factor:
Publication type: Paper in international publication
Authors: Bove, Jordi; de Fabregues, Oriol; de Fabregues, Oriol; Ramos-Vicente, David; Ramos-Vicente, David; Roch, Gerard; Roch, Gerard; Selles, Maria; Selles, Maria; Vila, Miquel et al.
DOI: 10.1016/j.nbd.2023.106308

Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes.

PMID: 34890878
Journal: PARKINSONISM & RELATED DISORDERS
Year: 2022
Reference: Parkinsonism Relat Disord. 2022 Jan;94:67-78. doi: 10.1016/j.parkreldis.2021.11.014. Epub 2021 Nov 25.
Impact factor:
Publication type: Paper in international publication
Authors: Adarmes, A; Artuch, R; Beyer, Katrin; Castano-de la Mota, C; De la Torre-Aguilar, Maria Jose; Fernandez-Ramos, Joaquin A; Garcia Cazorla, A; Gomez-Esteban, J C; Gonzalez Gutierrez-Solana, L; Hernandez-Vara, J et al.
DOI: 10.1016/j.parkreldis.2021.11.014

Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease.

PMID: 35085959
Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES
Year: 2022
Reference: J Neurol Sci. 2022 Mar 15;434:120148. doi: 10.1016/j.jns.2022.120148. Epub 2022 Jan 12.
Impact factor:
Publication type: Paper in international publication
Authors: Adarmes-Gomez, Astrid; Aramburu, Isabel Gonzalez; Arroyo, Sonia Escalante; Avila, Asuncion; Barbera, Miquel Aguilar; Bejr-Kasem, Helena; Campolongo, Antonia; Carrillo, Fatima; Ceberio, Jon Infante; de Deus Fonticoba, Teresa et al.
DOI: 10.1016/j.jns.2022.120148

Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke.

PMID: 34229512
Journal: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Year: 2022
Reference: J Cereb Blood Flow Metab. 2022 Feb;42(2):237-252. doi: 10.1177/0271678X211028816. Epub 2021 Jul 6.
Impact factor:
Publication type: Paper in international publication
Authors: Arrue, Mercedes; Belloli, Sara; Castellote, Laura; Garcia-Gabilondo, Miguel; Grayston, Alba; Kopcansky, Peter; Kovac, Jozef; Martin, Abraham; Moresco, Rosa M; Picchio, Maria et al.
DOI: 10.1177/0271678X211028816

Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group.

PMID: 34602501
Journal: Journal of Parkinsons Disease
Year: 2022
Reference: J Parkinsons Dis. 2022;12(1):315-331. doi: 10.3233/JPD-212868.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, Miquel; Alonso Losada, Maria G; Alonso Redondo, Ruben; Alvarez Sauco, Maria; Avila Rivera, Maria A; Blazquez Estrada, Marta; Borrue, Carmen; Caballol, Nuria; Cabo, Iria; Canfield, Hector et al.
DOI: 10.3233/JPD-212868

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.

PMID: 33978742
Journal: BRAIN
Year: 2021
Reference: Brain. 2021 Nov 29;144(10):3114-3125. doi: 10.1093/brain/awab191.
Impact factor:
Publication type: Paper in international publication
Authors: Arnulf, Isabelle; Biondetti, Emma; Corvol, Jean-Christophe; Dodet, Pauline; Gaurav, Rahul; Habert, Marie-Odile; Hutchison, Matthew; Lehericy, Stephane; Leu-Semenescu, Smaranda; Mangone, Graziella et al.
DOI: 10.1093/brain/awab191

Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up.

PMID: 33924567
Journal: Journal of Clinical Medicine
Year: 2021
Reference: J Clin Med. 2021 Apr 13;10(8). pii: jcm10081664. doi: 10.3390/jcm10081664.
Impact factor:
Publication type: Review in international publication
Authors: Agraz-Pamplona, Irene; Armengol-Bellapart, Mar; Arranz-Amo, Jose Antonio; Camprodon-Gomez, Maria; Carnicer-Caceres, Clara; Cea-Arestin, Cristina; Del-Toro-Riera, Mireia; Hernandez-Vara, Jorge; Lucas-Del-Pozo, Sara; Molto-Abad, Marc et al.
DOI: 10.3390/jcm10081664

Nurr1 repression mediates cardinal features of Parkinson's Disease in alpha-synuclein transgenic mice.

PMID: 33902111
Journal: HUMAN MOLECULAR GENETICS
Year: 2021
Reference: Hum Mol Genet. 2021 Jul 28;30(16):1469-1483. doi: 10.1093/hmg/ddab118.
Impact factor:
Publication type: Paper in international publication
Authors: Alexakos, Pavlos; Argyrofthalmidou, Maria; Katsianou, Maira A; Maniati, Matina; Manousaki, Maria; Papadopoulou-Daifoti, Zeta; Papapanagiotou, Ioanna; Perier, Celine; Pitychoutis, Pothitos M; Poula, Amalia et al.
DOI: 10.1093/hmg/ddab118

Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson's Disease.

PMID: 33885286
Journal: ACS Nano
Year: 2021
Reference: ACS Nano. 2021 May 25;15(5):8592-8609. doi: 10.1021/acsnano.1c00453. Epub 2021 Apr 22.
Impact factor:
Publication type: Paper in international publication
Authors: Bove, Jordi; Candiota, Ana Paula; Cavaliere, Ivana; Garcia-Pardo, Javier; Lope-Piedrafita, Silvia; Lorenzo, Julia; Nador, Fabiana; Novio, Fernando; Rodriguez-Galvan, Beatriz; Romero-Gimenez, Jordi et al.
DOI: 10.1021/acsnano.1c00453

Chitinase 3-like 1 is neurotoxic in primary cultured neurons.

PMID: 32346016
Journal: Scientific Reports
Year: 2020
Reference: Sci Rep. 2020 Apr 28;10(1):7118. doi: 10.1038/s41598-020-64093-2.
Impact factor:
Publication type: Paper in international publication
Authors: Calvo-Barreiro, Laura; Carballo-Carbajal, Iria; Comabella, Manuel; Gonzalo, Ricardo; Matute-Blanch, Clara; Montalban, Xavier; Sanchez, Alex; Vila, Miquel et al.
DOI: 10.1038/s41598-020-64093-2

The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype.

PMID: 32333181
Journal: NEUROLOGICAL SCIENCES
Year: 2020
Reference: Neurol Sci. 2020 Oct;41(10):2883-2892. doi: 10.1007/s10072-020-04404-7. Epub 2020 Apr 24.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso-Losada, Maria G; Alvarez-Sauco, Maria; Avila-Rivera, Maria A; Caballol, Nuria; Catalan, Maria J; Cubo, Esther; de Deus-Fonticoba, Teres; Escalante, Sonia; Feal-Painceiras, Maria J; Garcia-Caldentey, Juan et al.
DOI: 10.1007/s10072-020-04404-7

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.

PMID: 32202078
Journal: Brain and Behavior
Year: 2020
Reference: Brain Behav. 2020 May;10(5):e01596. doi: 10.1002/brb3.1596. Epub 2020 Mar 22.
Impact factor:
Publication type: Paper in international publication
Authors: Auger, Cristina; Cardona, Ignasi; De Fabregues, Oriol; Palasi, Antoni; Quintana, Manuel; Vargas, Victor; Vinas, Jaume et al.
DOI: 10.1002/brb3.1596

Non-motor symptoms burden is strongly correlated to motor complications in Parkinson s disease patients.

PMID: 32181979
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2020
Reference: Eur J Neurol. 2020 Jul;27(7):1210-1223. doi: 10.1111/ene.14221. Epub 2020 Apr 24.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, M; Almeria, Marta; Alonso Canovas, Araceli; Alonso-Frech, F; Alvarez Sauco, Maria; Aneiros Diaz, A; Angel Labrador Espinosa, Miguel; Angeles Boti Gonzalez, Maria; Angeles Prats, Marian; Arnaiz, Sandra et al.
DOI: 10.1111/ene.14221

Synaptic regulator alpha-synuclein in dopaminergic fibers is essentially required for the maintenance of subependymal neural stem cells.

PMID: 29217686
Journal: JOURNAL OF NEUROSCIENCE
Year: 2018
Reference: J Neurosci. 2018 Jan 24;38(4):814-825. doi: 10.1523/JNEUROSCI.2276-17.2017. Epub 2017 Dec 7.
Impact factor:
Publication type: Paper in international publication
Authors: Alarcon-Aris, Diana; Belen Munoz-Manchado, Ana; Belenguer, German; Bezard, Erwan; Bortolozzi, Analia; Dehay, Benjamin; Farinas, Isabel; Jose Toledo-Aral, Juan; Perez-Sanchez, Francisco; Perez-Villalba, Ana et al.
DOI: 10.1523/JNEUROSCI.2276-17.2017

Blog

News

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Coneix i participa al projecte VHIP

Vall d'Hebron Iniciativa per al Parkinson (VHIP) is a research project aimed at the development of biochemical markers for the early detection of Parkinson's disease. This study is carried out in people at high risk of having this disease, because they carry genetic mutations that predispose to the development of Parkinson's or because they present non-motor symptoms that manifest themselves years before motor symptoms.

Access the project and study